Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.293 SEK | +1.03% | +22.08% | -10.40% |
May. 20 | Spago Nanomedical Provides an Update on Tumorad-01, Trial Proceeds as Planned | CI |
May. 02 | Spago Nanomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- SPAG Stock
- News Spago Nanomedical AB
- MarketScreener Strategies